Investigational Site Number 902

Seattle, Washington 98101-3932

0 studies enrolling now · 1 studies all time

What they study most

Factor VIII Deficiency

Studies at this site

• A Phase 3 Open-label Interventional Study of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein, Efanesoctocog Alfa (BIVV001), in Patients With Severe Hemophilia A — Completed